Biotie being courted by potential partners for Alzheimer’s drugBloomberg Businessweek20 February 2012---------Panu Miettinen appointed chief financial officer of BiotieInPharm16 February 2012---------Lundbeck seeks approval for a novel alcoholism treatmentPharma and Healthcare Insight30 December 2011---------Biotie tests cocaine dependence treatment in USAPharma Times14 December 2011--------Scandinavian biotech hit particularly hard in bad year for sectorEPVantage from EvaluatePharma2 December 2011--------Biotie pulls out of merger with Newron Pharma Times28 October 2011---------Biotie initiates SYN120 Phase 1 study using PET imagingMedical Devices Business Review25 July 2011---------
Lundbeck to file alcoholism pill this yearInPharm16 June 2011---------Lundbeck to file alcoholism drug in Europe by year endPharma Times16 June 2011---------
Lundbeck finishes alcohol dependency trialsPMLiVE15 June 2011---------Lundbeck nails PhIII for drug to curb alcohol dependenceFierceBiotech15 June 2011----------
Nalmefene reaches Phase III endpointsEuropean Biotechnology News6 February 2011----------
Biotie to acquire CNS therapeutics firm Synosia in €93.6M all-shares dealGenetic Engineering & Biotechnology News11 January 2011----------
Biotie buys CNS developer Synosia in $121.5M dealFierceBiotech11 January 2011-----------
Alcoholics may stop at one drink with help from Lundbeck anti-abuse drugBloomberg23 December 2010--------------------Päivitetty 21.2.2012